F 
67.35
+4.60%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$1.10bn
FY2016FY2025
Net income
$139.1m
FY2016FY2025
Free cash flow
$12.4m
FY2016FY2025
Shareholders' equity
$1.21bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.10bn | $975.2m | $766.9m | $595.3m | $425.5m | $318.8m | $245.9m | $193.2m | $156.4m | $133.1m |
| Gross profit | $425.2m | $396.0m | $250.9m | $186.0m | $162.1m | $132.9m | $114.2m | $90.0m | $72.4m | $60.4m |
| Research and development | — | — | — | — | — | $800,000 | $1.2m | $486,797 | $284,574 | $470,150 |
| Operating income | $95.0m | $38.4m | −$32.3m | −$54.0m | −$26.7m | −$1.9m | −$253,000 | −$5.0m | −$3.3m | −$2.4m |
| Net income | $139.1m | $46.9m | −$33.6m | −$59.5m | −$29.7m | −$3.2m | −$1.4m | −$5.4m | −$4.3m | −$3.2m |
| Diluted earnings per share | 2.48 | 0.93 | -0.67 | -1.24 | -0.68 | -0.08 | -0.04 | -0.15 | -0.12 | -0.09 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.78bn | $1.57bn | $1.46bn | $1.13bn | $784.4m | $434.4m | $236.1m | $140.0m | $133.9m | $126.5m |
| Cash and short-term investments | $278.0m | $268.6m | $296.9m | $132.7m | $72.8m | $67.2m | $9.5m | $7.6m | $2.2m | $3.9m |
| Total liabilities | $569.1m | $519.5m | $511.0m | $93.8m | $64.7m | $40.2m | $104.9m | $18.5m | $17.0m | $18.7m |
| Debt | $401.9m | $420.6m | $421.2m | — | — | — | $54.5m | — | — | $7.0m |
| Shareholders' equity | $1.21bn | $1.06bn | $953.5m | $1.03bn | $719.8m | $394.2m | $131.3m | $121.5m | $116.9m | $107.8m |
| Shares outstanding | 56m | 50m | 50m | 48m | 43m | 41m | 37m | 37m | 36m | 34m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $160.6m | $154.3m | $75.9m | −$43.2m | $647,000 | $21.2m | $16.3m | $18.6m | $10.3m | $12.8m |
| Capital spending | −$148.2m | −$187.1m | −$239.1m | −$230.1m | −$322.1m | −$134.6m | −$70.6m | −$16.3m | −$13.0m | −$30.0m |
| Free cash flow | $12.4m | −$32.8m | −$163.2m | −$273.3m | −$321.5m | −$113.4m | −$54.3m | $2.3m | −$2.7m | −$17.2m |
| Dividends paid | — | — | −$780.8m | −$1.4m | — | −$2.6m | −$1.3m | — | — | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $305.6m | $297.6m | $285.2m | $288.8m | $264.7m | $263.2m | $262.7m | $253.4m |
| Gross profit | $128.7m | $120.7m | $104.8m | $108.4m | $108.2m | $103.8m | $111.6m | $102.2m |
| Operating income | $14.3m | $5.0m | $52.2m | $25.7m | $17.8m | −$11.5m | $19.4m | $11.9m |
| Net income | $19.5m | $48.5m | $33.8m | $101.7m | $16.4m | −$12.7m | $18.1m | $11.9m |
| Diluted earnings per share | 0.35 | 0.87 | 0.60 | 1.81 | 0.29 | -0.23 | 0.36 | 0.24 |
| Cash from operations | $44.0m | $40.0m | $55.0m | $66.0m | $33.0m | $4.0m | $50.0m | $56.0m |
| Capital spending | −$29.0m | −$27.0m | −$54.0m | −$35.0m | −$7.0m | −$26.0m | −$58.0m | −$34.0m |
| Free cash flow | $15.0m | $13.0m | $1.0m | $31.0m | $26.0m | −$22.0m | −$8.0m | $22.0m |
| Total assets | $1.81bn | $1.84bn | $1.78bn | $1.75bn | $1.65bn | $1.56bn | $1.57bn | $1.53bn |
| Cash and short-term investments | $350.8m | $381.4m | $278.0m | $274.6m | $243.7m | $243.7m | $268.6m | $274.6m |
| Debt | $403.0m | $402.6m | $401.9m | $401.2m | $400.5m | $399.2m | $398.6m | $398.0m |
| Shareholders' equity | $1.24bn | $1.26bn | $1.21bn | $1.18bn | $1.07bn | $1.05bn | $1.06bn | $1.02bn |
Financial ratios
Data as of 23 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 38.6% | 40.6% | 32.7% | 31.2% | 38.1% | 41.7% | — | — | — | — |
| Operating margin | 7.7% | 6.1% | -2.3% | -8.4% | -5.8% | -0.6% | — | — | — | — |
| Net margin | 12.6% | 4.8% | -4.4% | -10.0% | -7.0% | -1.0% | — | — | — | — |
| Return on equity | 11.5% | 4.4% | -3.5% | -5.8% | -4.1% | -0.8% | — | — | — | — |
| Return on assets | 7.8% | 3.0% | -2.3% | -5.3% | -3.8% | -0.7% | — | — | — | — |
| Free cash flow yield | 8.2% | 10.1% | 9.4% | 5.8% | 11.1% | 5.7% | — | — | — | — |
| Revenue growth | 13.0% | 27.2% | 28.8% | 39.9% | 33.5% | 29.7% | — | — | — | — |
| Earnings growth | 196.5% | -239.6% | -43.5% | 100.3% | 831.6% | 130.5% | — | — | — | — |
| Current ratio | 5.54x | 4.42x | 4.79x | 2.92x | 2.55x | 3.29x | — | — | — | — |
| Debt to equity | 0.33x | 0.38x | 0.42x | 0.00x | 0.00x | 0.00x | — | — | — | — |
| Equity ratio | 68.0% | 67.0% | 65.1% | 91.7% | 91.8% | 90.7% | — | — | — | — |
| Interest coverage | 6.01x | 4.88x | -1.24x | -9.65x | -8.55x | -1.58x | — | — | — | — |
| R&D as a share of sales | — | — | — | — | — | 0.3% | 0.5% | 0.3% | 0.2% | 0.4% |
| Buybacks as a share of market value | -11.2% | -1.0% | -3.9% | -10.6% | -6.7% | -8.9% | — | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 22.8% | 28.2% | 25.2% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 39.5% | 36.6% | 37.1% | 38.7% |
| Operating margin | 6.4% | 1.4% | 0.4% | 0.1% |
| Net margin | 9.0% | 2.7% | 1.4% | 0.8% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 24.5 | 159.1 | -128.8 | -42.6 | -139.2 | -1811.3 | -1596.2 | -221.7 | -159.3 | -109.9 |
| Price to sales | 3.1 | 7.7 | 5.6 | 4.3 | 9.7 | 18.1 | 9.0 | 6.2 | 4.3 | 2.6 |
Market value over time
30 Nov 2016 to 22 Oct 2026, in USD
$316.1m$3.74bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -53% | 64% | 63% | -42% | -35% | 142% | 82% | 62% | 96% | 20% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.